| Audit Committee | Compensation Committee | Nominating and Governance Committee | |
|---|---|---|---|
| Michael B. Hoffman | Compensation Committee | Nominating and Governance Committee | |
| Henry S. Bienen Ph.D. | Audit Committee | ||
| Jerome E. Groopman M.D. | Nominating and Governance Committee | ||
| James J. Marino Esq. | Audit Committee | Compensation Committee | |
| Viren Mehta Pharm.D. | Audit Committee | Nominating and Governance Committee | |
| Jack E. Stover | Audit Committee | Compensation Committee |
Onconova Therapeutics, Inc. is a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer.
